drugset / Trial / NCT06477926
A Study to Assess Relative Bioavailability and Food Effect of ABBV-668 Extended-Release Formulations in Adult Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The objectives of this study are to assess safety and tolerability of the new ABBV-668 ER tablets, to assess the oral bioavailability of the ABBV-668 ER tablets relative to the ABBV-668 IR capsules, and to assess the pharmacokinetics of the ER tablets under fasting and fed conditions in healthy adults.
Timeline
- Start
- 2024-07-09
- Primary completion
- 2024-09-20
- Completion
- 2024-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-668 | Unknown | — | Oral |
Indications
No indication recorded.